Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ChIP-Seq analysis of H3K27ac following HDAC1,2 inhibition

ABSTRACT: The goal of this study is to examine H3K27ac genome-wide in leukemic cells treated with HDAC1,2 inhibitor

ORGANISM(S): Homo sapiens

PROVIDER: GSE99443 | GEO | 2021/07/01

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Genome-wide nuclesome occupancy following HDAC1,2 inhibitor treatment

Project description:The goal of this study is to identify nucleoosme occupancies in leukemic cells treated with HDAC1,2 inhibitor

2021-07-01 | GSE99442 | GEO

Genome-wide nuclesome occupancy following HDAC inhbitor and/or doxorubicin treatment

Project description:The goal of this study is to identify nucleosome occupancies in leukemic cells treated with either HDAC inhibitor or doxorubicin or HDAC inhibitor plus doxorubicin

2021-07-01 | GSE86784 | GEO

Mitochondrial Fission 1 (FIS1) knockdown effect on the H3K27Ac status of leukemia cell line MOLM-13 cells

Project description:To examine if loss of FIS1 would alter the H3K27Ac status of leukemic cells, we used shRNA to knock down the expression of FIS1 in leukemic cell line MOLM-13 cells and performed H3K27Ac CHIP-seq to characterize any changes in the H3K27Ac marks upon loss of FIS1.

2018-06-01 | GSE114106 | GEO

Regulatory T cell modulation by CBP/EP300 bromodomain inhibition [ChIP-seq]

Project description:Genome-wide chromatin H3K27ac, H3K18ac and H3K4me3 occupancy changes in response to CBP inhibitor treatment in Treg cells using ChIP sequencing (ChIP-seq). Expression profiling by ChIP-seq of Treg cells treated with DMSO or CBP inhibitor

2016-04-06 | E-GEOD-70708 | biostudies-arrayexpress

H3K27ac ChIP-Seq in ALL-SIL

Project description:The T-cell leukemia homeobox 1 (TLX1, HOX11) transcription factor is critically involved in the multistep pathogenesis of T-cell acute lymphoblastic leukemia (T-ALL) and often cooperates with NOTCH1 activation during malignant T-cell transformation. However, the exact molecular mechanisms by which these T-cell specific oncogenes cooperate during transformation remain to be established. Here, we used an integrative genomics approach to show that the oncogenic properties of TLX1 are mediated by genome-wide interference with the ETS1 and RUNX1 transcription factors. Partial disruption of ETS1 and RUNX1 activity by ectopic TLX1 expression in immature thymocytes drives repression of T-cell specific super-enhancers and mediates an unexpected transcriptional antagonism with NOTCH1 signaling. These phenomena coordinately trigger a TLX1 driven pre-leukemic phenotype in human thymic precursor cells, which corresponds with the in vivo thymic regression observed in murine TLX1 tumor models, and creates a strong genetic pressure for acquiring activating NOTCH1 mutations as a prerequisite for full leukemic transformation. In conclusion, our results uncover a functional antagonism between cooperative oncogenes during the earliest phases of tumor development and provide novel insights in the multistep pathogenesis of TLX1 driven human leukemia. ChIP-sequencing data was generated for H3K27ac in the T-ALL cell line ALL-SIL.

2015-08-05 | E-GEOD-70734 | biostudies-arrayexpress

CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [ChIP-seq]

Project description:We recently reported the discovery of a small molecule inhibitor, AI-10-49 which can specially inhibit the protein-protein interaction between RUNX1 tumor suppressor and CBFβ-SMMHC oncogene. We also demonstrated that AI-10-49 can re-establish the RUNX1 transcriptional program in inv(16) cells and can extend the survival of inv(16) leukemic mice. To identify the epigenetic changes as well as RUNX1 binding associated with AI-10-49, we performed genome wide analysis of H3K27ac histone mark as well as RUNX1 bindings in ME-1 cells [human inv(16) leukemia cell line] treated with AI-10-49.

2018-05-02 | GSE101789 | GEO

Next Generation Sequencing of RNA from HDAC inhibitor and/or doxorubicin treated samples

Project description:Our study represents the first detailed analysis of transcriptomes in HDAC inhibitor and doxorubicin treated leukemic cells. The goal of this study is to identify gene expression patterns in HDAC and/or doxorubicin treated leukemic cells

2021-07-01 | GSE86783 | GEO

Genomewide profiling of H3K27ac following HDAC1/2 inhibition with romidepsin and evaluation of co-regulated mechanisms by HDAC2 and SMAD3 in BTSC genome.

Project description:To investigate the impact on global H3K27ac patterns following HDAC1/2 inhibition with romidepsin, we performed using ChIP-seq using formaldehyde crosslinked BT67 romidepsin treated versus vehicle treated cells.

2023-07-09 | GSE214926 | GEO

H3K27ac ChIP-Seq in LOUCY

Project description:H3K27ac ChIP-Seq data of the T-ALL cell line LOUCY was obtained to find active regions in the genome and to correlate that with expression profiling of lncRNAs in the LOUCY cell line. ChIP-sequencing data was generated for H3K27ac in the T-ALL cell line LOUCY.

2016-05-17 | E-GEOD-74311 | biostudies-arrayexpress

H3K4me3 and H3K27ac ChIp-seq

Project description:H3K4me3 and H3K27ac ChIp-seq

| PRJNA512869 | ENA